Th17 cells reactive to the enteric microbiota are central to the pathogenesis of certain types of inflammatory bowel disease. However, Th17 cells display substantial developmental plasticity, such that some progeny of Th17 cell precursors retain a predominantly IL-17A + phenotype, whereas others extinguish IL-17 expression and acquire expression of IFN-γ, giving rise to "Th1-like" cells. It remains unclear what role these subsets play in inflammatory bowel disease. Using a Th17 transfer model of colitis, we found that IFN-γ-deficient Th17 cells retained an IL-17A
+ phenotype and were unable to induce colitis in recipients. Development of disease required the transition of a subset of Th17 precursors to Th1-like cells and was contingent on the expression of both Stat4 and T-bet, but not the IL-12 or IFN-γ receptors. Moreover, Th17 cells could provide "help" for the development of pathogenic Th1 cells from naïve precursors. These results indicate that Th17 cells are potent mediators of colitis pathogenesis by dual mechanisms: by directly transitioning to Th1-like cells and by supporting the development of classic Th1 cells.
Th17 | Th1 | colitis T he discovery that Th17 cells are products of a developmental pathway distinct from that of Th1 and Th2 cells has had a major impact on our understanding of immune regulation and dysregulation in the intestines (1) . Before this, a commonly held view was that Th1 cells were the principals in inflammatory bowel disease (IBD) pathogenesis (2) (3) (4) (5) . Subsequently, however, numerous studies have shown that IL-23, a Th17 pathway cytokine, is required for development of IBD (6) (7) (8) , as is expression of the IL-23 receptor by CD4 + T cells (9) . Moreover, diseaseassociation studies in humans have implicated a number of genes that are Th17-specific (10) , and Th17 cells are now thought to be the principal effector cell in IBD.
Despite this, our own and other studies have found a mix of IL-17A + and IFN-γ + cells during active intestinal inflammation in T-cell transfer models of colitis in mice (9, 11, 12) , consistent with human data showing that CD4 T cells from the diseased intestines of patients with Crohn's disease express IL-17A, IFN-γ, or both (13) . Accordingly, although the Th17 pathway appears to be central to IBD pathogenesis, T cells expressing the signature Th1 lineage cytokine, IFN-γ, are consistently associated with the inflammatory lesions of colitis. Furthermore, there remains a strong association of disease with the Th1 pathway in mouse models. Antibody-mediated neutralization of IFN-γ inhibited the development of colitis in early studies of the CD45RB hi transfer model of colitis (3) , as did transfers of naïve T cells deficient for IFN-γ (4) or the Th1 lineage transcription factors, T-bet and Stat4 (5, 14) .
A reconciliation of these findings has been suggested by discovery that Th17 cells retain significant late developmental plasticity (1, 11) . Specifically, developing Th17 cells can diverge to acquire Th1-like features contingent on IL-12 or IL-23 signaling, both of which activate Stat4 and induce expression of T-bet that represses expression of the signature Th17 transcription factor, RAR-related orphan receptor (ROR)γt, and leads to extinction of Il17a and Il17f expression and induction of Ifng expression (11, 15, 16) . Thus, in addition to production of IL-17A and IL-17F, the Th17 pathway can also give rise to "Th1-like" cells that produce IFN-γ. Accordingly, we found that Th17 cells isolated using an IL-17F reporter transgene induced severe colitis that was associated with recovery of Th1-like cells derived from the Th17 precursors (11) . In view of findings that T cells deficient for IL-17A induced colitis that is indistinguishable from (17, 18) or more severe than controls, and this disease was associated with increased frequencies of Th1-like cells (19) , these results are consistent with a pathogenic role for Th1-like cells that emerge from Th17 precursors.
Here, we examined mechanisms by which Th1-like cells arise from Th17 precursors in vivo and their possible contribution to colitis pathogenesis. We found that IFN-γ production by the progeny of Th17 cells was required for disease development in a transfer model of Th17-driven colitis: this was T-bet-and, to a lesser extent, Stat4-dependent. Moreover, Th17 cells unable to produce IFN-γ promoted the development of colitis from naïve precursors deficient in RORγt, establishing Th17-dependent support for the differentiation of pathogenic Th1 cells that do not develop via the Th17 pathway.
Results and Discussion IFN-γ Produced by Th17 Cells Is Indispensible for Colitis Induction. We have reported a Th17 transfer model of colitis that enables study of Th17 cell plasticity in the pathogenesis of intestinal inflammation (11) . In this model, Th17-polarized cells are generated from naive CD4 + T cells of IL-17F reporter mice (Il17f
Thy1.1
) and sorted on the basis of Thy1.1 (IL-17F) expression. IL-17F is the dominant IL-17 family cytokine produced by Th17 cells early in development and is thus an ideal marker for Th17 commitment. Importantly, Thy1.1 + Th17 cells do not express IFN-γ after in vitro polarization (11) . Transfers of isolated IL-17F + Th17 precursor (Th17p) cells into recombination activating gene (RAG)1-deficient recipients results in colitis that is of
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The Th17 subset of CD4 + T cells are important in the pathogenesis of inflammatory bowel disease (IBD), but the mechanisms of their actions, particularly the role of the development of IFN-γ-producing progeny of Th17 cells (Th1-like cells), are incompletely understood. Here, we show in a mouse model of Th17-driven IBD that transition of Th17 precursors to Th1-like cells is absolutely required for disease, because Th17 cells deficient in IFN-γ fail to induce intestinal inflammation. This transition is dependent on the transcription factors T-bet and, to a lesser extent, Stat4. These findings are relevant for clinical strategies that target IBD and suggest that focusing on both the Th17 and Th1-like arms of disease may be beneficial in therapy design.
comparable severity, but accelerated onset, compared with that caused by transfers of CD45RB hi CD4 + T cells (11) . Importantly, T cells recovered following the onset of colitis in the Th17 transfer model have diverged into distinct subsets, such that some progeny of transferred Th17p cells retain expression of IL-17A, with or without coexpression of IFN-γ, whereas others silence expression of IL-17A and IL-17F while acquiring expression of IFN-γ.
To probe the role of Th17 cell-derived IFN-γ in the development of colitis, we examined the pathogenic potential of Th17 precursors derived from IFN-γ-deficient IL-17F reporter mice. CD4
) were polarized ex vivo under Th17-inducing conditions using Il12b −/− splenic feeder cells to ensure absence of IL-23 and IL-12 ( Fig. 1A and Fig. S1A) . A large percentage of cells expressed Thy1.1 (IL-17F), and the majority of cells that expressed IL-17A were a subset of those expressing IL-17F (Fig. S1B) (11) . Polarized cells were sorted for Thy1.1 expression (Fig. S1C ) and transferred into Rag1 −/− recipients. Transfers of Th17p cells from WT mice induced substantial disease, indicated by significant weight loss (Fig. 1B) as well as severe colonic inflammation ( Fig. 1 C and D) by 4 wk after transfer. In contrast, Th17p cells from Ifng −/− mice failed to induce wasting disease (Fig. 1B ) or significant colonic inflammation ( Fig. 1 C and D) . Thus, production of IFN-γ by Th17p cells is essential for development of Th17-mediated colitis.
Flow cytometric analysis of T cells recovered from the colonic lamina propria (CLP) and mesenteric lymph nodes (MLN) showed that four distinct populations of cells emerged from recipients of WT Th17p cells ( Fig. 1 E and F) . A minor fraction of recovered cells retained IL-17A expression alone, with a similar percentage expressing both IL-17A and IFN-γ. Notably, a large percentage of recovered cells expressed IFN-γ alone, despite undetectable IFN-γ in the sorted cells before transfer (Fig. S1A) . This finding demonstrates that many Th17p cells have transitioned in vivo to become IFN-γ-producing Th1-like cells. In contrast, T cells recovered from the MLN and CLP of recipients of IFN-γ-deficient Th17 p displayed increased frequencies of IL-17A-expressing cells, with an absence of cells expressing IFN-γ or both cytokines ( Fig. 1 E and F) . Increased frequencies of IL-17A + cells in these recipients were also associated with an increase in cells expressing Thy1.1 (IL-17F), IL-22, and GM-CSF compared with WT recipients (Fig. S2B) but not IL-10, which was extinguished in both groups. Notably, because there were significantly decreased total CD4 T cells recovered from the colons of these mice, only the number of IL-22 and Thy1.1 cells were significantly higher than WT recipients, meaning that the absolute numbers of IL-17A-expressing cells was not significantly different from WT controls in which there was marked colonic inflammation (Fig. 1G) . Thus, the absence of disease in recipients of IFN-γ-deficient Th17p cells could not be attributed to a deficit of colonic IL-17A + Th17 cells. In view of the requirement for IFN-γ expression by transferred Th17p cells for disease induction, we determined whether IFN-γ might act to enhance the transition of Th17p to Th1-like cells as a mechanism to promote colitis. Transfer studies were performed using Th17p cells that could, or could not, respond to IFN-γ. Thy1.1 (WT), but these results did not achieve statistical significance, indicating that actions of IFN-γ on transferred Th17 cells were of lesser import than its actions on host cells. T cells recovered from the CLP of Ifngr1 −/− recipients had significantly higher expression of IL-17A compared with WT Th17p recipients (Fig. S3D ), suggesting that IFN-γ signaling in Th17 cells inhibits IL-17A production by cells in the colonic mucosa. Interestingly, this pattern did not repeat in the MLN, suggesting that the actions of IFN-γ might be relatively restricted to the intestinal mucosa or that the actions of IFN-γ on Th17 cells promote their retention or localization in the mucosa. Despite their deficiency in IFN-γ signaling, recovered CD4
+ cells from CLP of Ifngr1 −/− Th17p recipients expressed comparable levels of T-bet in all cytokine-producing fractions (Fig. S3 F and G), suggesting that other signals, such as type I interferons, might partially compensate for the lack of IFN-γ signaling (20) .
The foregoing findings indicated that transferred Th17p cells were not the principal targets of the actions of IFN-γ that contribute to colitis. Given that IFN-γ acts on a broad range of cells (21, 22) , we extended these findings by examining the effect of neutralizing antibodies to IFN-γ in recipients of Th17p cells that lacked expression of the IFN-γ receptor. Consistent with the previous results, administration of neutralizing anti-IFN-γ mAb recipients. Data are representative of three independent experiments with five mice per group. *P < 0.05, **P < 0.01, ***P < 0.001.
significantly ameliorated disease in Rag1 −/− mice that received transfers of Ifngr1 −/− Th17p cells compared with those that received an isotype control mAb (Fig. S3H) .
Collectively, these data established that production of IFN-γ by Th1-like cells that arose from Th17 precursors was required for the development of colitis. Production of IFN-γ by innate immune cells of Rag1 −/− recipients, which were IFN-γ competent, did not complement the IFN-γ deficiency in transferred Th17 cells. Although IFN-γ signaling had a detectable impact on the development of Th17 cells posttransfer, this did not significantly affect disease development. These results indicate that the principal targets of IFN-γ that induce disease are non-T cells.
Stat4, but Not IL-12, Signaling in Th17 Cells Is Required for Colitis.
IL-12 signaling via Stat4 is critical for the second "wave" of Th1 differentiation, which is believed to sustain and stabilize the Th1 phenotype (23). Although not required for Th17 development (24, 25) , we have reported that IL-12 can enhance IFN-γ production from in vitro-derived Th17 cells in a Stat4-dependent manner (11) . However, IL-23, not IL-12, has been linked to immune-mediated colitis (9, 26) , and the IL-23 driven divergence of Th17p cells to a Th1-like phenotype in vitro is Stat4-dependent (11, 15) . Moreover, Th17 cells that develop in vivo lack expression of Il12rb2 (27) , suggesting that the pathway to IFN-γ production by Th17 cells in vivo is contingent on Stat4 activation downstream of IL-23, not IL-12, signaling.
To directly examine the roles of IL-12 and Stat4 in Th17-derived IFN-γ production and colitis development, IL-12Rβ2-and Stat4-deficient IL-17F reporter mice were generated. Th17p cells derived from Il17f
Thy1.1 (WT), Il12rb2
Thy1.1
, and Stat4
have comparable cytokine phenotypes ( Fig. 2A) −/− Th17p cells showed a significant reduction in colonic inflammation ( Fig. 2 B and C) .
Reduced disease in recipients of Stat4 −/− Th17p cells correlated with a relative decrease in colonic IFN-γ + T cells and a reciprocal increase IL-17A
+ and IL-17A + IFN-γ + (Fig. 2D) . In draining MLN, there were also decreased frequencies of single IFN-γ + T cells, although no significant changes in IL-17A + or IL-17A + IFN-γ + cells were detected. Thus, although IFN-γ expression was significantly reduced in T cells recovered from Stat4 −/− Th17p recipients, it was not completely ablated, consistent with reduced, but not absent, colitis development.
Concomitant with reduced IFN-γ production by Stat4 −/− Th17p cells was a significant reduction in T-bet expression in both the IL-17A + IFN-γ + and IFN-γ + CLP fractions (Fig. 2E ). Because T-bet expression can be induced by either Stat1 or Stat4 signaling, Stat1 might partially compensate for Stat4 in this setting. Interestingly, although T-bet was also significantly reduced in IFN-γ + cells recovered from the CLP of Il12rb2 −/− recipients (Fig. 2E) , this was not associated with a significant decrement in recovered IFN-γ + cells or with reduction in disease. Accordingly, whereas the pathogenic transition of Th17p cells to Th1-like cells was at least partially dependent on Stat4 signaling, IL-12 signaling was dispensable. This finding is consistent with a dominant role for IL-23-driven Stat4 signaling in Th1-like transition and disease in the gut.
T-bet Is Indispensable for Th17 Transition to Th1-Like Cells and Induction of Colitis. T-bet is a central transcription factor required for Th1 cell programming and Ifng expression, and was shown in previous studies to be required for the transition of Th17p cells into Th1-like cells (11, 15) . To examine the requirement for T-bet in Th17-derived IFN-γ production and colitis pathogenicity, Th17p cells derived from Il17f
Thy1.1 (WT) and Tbx21 Impairment of disease in Tbx21 −/− recipients was associated with a marked reduction in single IFN-γ + T cells in both the CLP and MLN (Fig. 3 B and C) . There were reciprocal increases in frequencies of IL-17A + cells. This was accompanied by an increase in expression of IL-17F by recovered T cells, which was virtually undetectable in cells recovered from WT mice (Fig.  S4 B and C) , demonstrating a role for T-bet in suppressing of both IL-17A and IL-17F in vivo. Cells recovered from Tbx21 −/− recipients also expressed increased IL-22 ( Fig. S4 D and E) . Thus, consistent with results from transfers of Ifng −/− Th17p cells (Fig. 1 
IFN-γ
+ cells in the intestine were increased (Fig. 3  B and C) and their absolute numbers did not significantly decline (Fig. 3D) , despite the marked reduction of inflammatory T-cell infiltrates in the intestines of recipients of Tbx21 −/− Th17 cells (Fig. 3A and Fig. S4 ). Thus, in contrast to single IFN-γ + cells, expression of IFN-γ by these double-positive cells was largely T-bet-independent. Additionally, despite their capacity for IFN-γ expression, this subset was associated with substantially reduced colitis, suggesting that either the levels of IFN-γ expression by these cells was insufficient to drive robust disease or that T-bet-dependent factors in addition to IFN-γ are required. .Ifng/Thy1.1 BAC-In (Tg) is able to report Ifng gene expression but not express IFN-γ. All cells were sorted for Thy1.1 expression (Fig.  S5B ) to obtain purified Th1 or Th17p cells, respectively, and were transferred into Rag1 −/− recipients. Both Th17p and Th1 cells induced weight loss and inflammation in the colon of Rag1 −/− recipients, compared with recipients of Ifng −/− Th1 cells, which did not display evidence of wasting or disease (Fig. S5 C and D) . These results suggest that although Th1-like and Th1 cells may have different molecular signatures, they induce comparable disease that is IFN-γ-dependent.
Th17 and Th1 Cells Cooperate to Induce Colitis. CD4 + T cells deficient in RORγt and IL-23R are unable to induce colitis despite being IFN-γ competent, indicating that Th17 development is critical for colitis induction (9, 29) . Nevertheless, Th1 cells derived ex vivo were comparable to Th17 cells in their ability to drive disease (Fig. S5) . This finding raised the possibility that Th17 cells might provide an environment wherein the two subsets cooperate to induce disease. To address this possibility, naïve CD4
hi ("RB hi ") cells from Rorc −/− mice, which cannot develop into Th17 cells, were cotransferred with Th17p cells from Ifng −/− mice that are nonpathogenic (Fig. 4) . In contrast to recipients of WT Th17 or WT RB hi cells, minimal disease was seen in recipients of IFN-γ-deficient Th17 cells or RORγt-deficient RB hi cells alone (Fig. 4A) . However, cotransfer of these cells induced disease comparable to recipients of WT RB hi cells. This finding was associated with significant increases in the percentage (Fig. 4C) and number (Fig. 4D) (Fig. 4D) . Notably, the number of IL-17A -
+ cells in the CLP of cotransfer recipients was not significantly different from recipients of WT RB hi cells, whereas the number of these cells in recipients of Rorc −/− RB hi cells alone was significantly reduced. Thus, deficiency in pathogenicity of IFN-γ-deficient Th17 cells or RORγt-deficient T cells was reversed by cotransfers of these populations, implying that Th17 cells can support the de novo development and pathogenicity of classical Th1 cells in vivo.
In this study, we have shown that Th17 cells can play dual roles in the development of colitis. First, we find that Th1-like cells that develop from Th17p cells are required for the pathogenesis of Th17-driven colitis, at least in part because of the IFN-γ they produce. In view of previous studies that have identified a central role for IL-23 in IBD pathogenesis (6) (7) (8) , our findings support a model wherein IL-23 produced by innate cells of the intestine acts on developing Th17 cells to deviate their differentiation to Th1-like cells by up-regulating T-bet and repressing RORγt expression, through a mechanism that is largely Stat4-dependent. 
WT Th17p
Ifng -/-Th17p Data are pooled from two independent experiments (mean + SEM). *P < 0.05, **P < 0.01, ***P < 0.001.
Second, we find that Th17 cells unable to produce IFN-γ themselves can support the de novo development of pathogenic Th1 cells from precursors blocked for Th17 development. Although a caveat of the current study is the use of effector T cells derived ex vivo, which might not completely parallel cells that develop in vivo, the results appear to reconcile early studies that identified a link to the Th1 pathway in IBD pathogenesis and subsequent studies that supported a principal role for the Th17 pathway: the inherent tendency for Th17 cells to deviate to Th1-like progeny driven by IL-23 combined with their capacity to support the development of pathogenic Th1 cells independently of the Th17 pathway provide the basis for a unified hypothesis wherein IL-23, the Th17 pathway, Th17-derived Th1-like cells, and classic Th1 cells are all contributory. With regard to mechanisms by which Th1-like cells arise from Th17p in the intestines, we find that T-cell expression of T-bet is critical, that Stat4 is contributory, and that IFN-γ and IL-12 signaling are dispensable. The finding that deficiency of Stat4 significantly reduced disease severity, whereas deficiency of IL-12Rβ2 did not, indicates that IL-23-driven Stat4 signaling is the major contributor to the development of pathogenic Th1-like cells from Th17p, consistent with a critical role for IL-23 signaling in T cells in colitis (9, 11) . Although at least some transferred Th17 cells appeared to have received IL-12 signaling, as evidenced by reduced levels of T-bet expression by Th1-like cells derived from Il12rb2 −/− Th17 cells, this contribution was clearly not required for colitis. Moreover, the greater impact on disease contributed by Stat4, despite comparable reductions in T-bet expression, imparted by deficiencies of IL-12Rβ2 and Stat4, is consistent with findings that the targets of transcriptional regulation by Stat4 and T-bet are not synonymous (30) .
Our finding that T-bet expression by Th17 cells is required for their transition to Th1-like cells and colitis pathogenesis is concordant with a recent study that identified a similar requirement for T-bet, as well as Runx factors, in experimental autoimmune encephalomyelitis (EAE) mediated by Th17 cells transfers (16) . Interestingly, other studies suggest that T-bet expression by T cells is not absolutely required for EAE pathogenesis, although disease was blunted in its absence (31, 32) . This finding might reflect differences in the role of T-bet in the Th17 to Th1 transition of Th17 cells differentiated ex vivo versus those that differentiate in vivo, which warrants further study. Interestingly, however, in each of these studies, a population of IL-17A
T cells developed in the absence of T-bet expression by CD4
+ T cells, consistent with findings herein. Whereas these dual positive cells appear to be nonpathogenic in the intestines, their presence was associated with disease in EAE in at least one study (31) . These findings expose likely differences between pathogenesis in the intestines and CNS. However, a role for IL-23-dependent IFN-γ production in the inflamed CNS was reported (27) , suggesting the emergence of Th1-like cells from Th17 precursors may be a common feature of these two diseases. Nevertheless, a uniform deficit of single IFN-γ + cells in the absence of T-bet supports a central role for T-bet in the generation of this population, indicating that T-bet is required to fully inhibit Rorc and the Il17a/Il17f gene locus and completion of the transition to Th1-like cells (15, 16) . The mechanism by which dual IL-17A + IFN-γ + cells arise in the absence of T-bet and what role they play in colitis is a subject for future studies, especially in view of their possible association with disease in T-bet sufficient mice (9) . Furthermore, given that expression of IFN-γ by T cells is essential for colitis induction, and that its pathogenic actions appear to be primarily targeted to non-T cells, it will be important to determine which cells targeted by IFN-γ are critical to disease. (35) . Flagellin is a dominant antigen in Crohn's disease patients (36) , consistent with a role for this pathway of IL-23 production in disease development. Taken together, these findings support a model where initial Th17 development in the intestine is promoted, and these cells both deviate into pathogenic Th1-like cells as well as support the development of Th1 cells that do not arise from the Th17 developmental program. Future studies will be necessary to elucidate the mechanisms by which this support occurs.
The role of IFN-γ in colitis has been controversial. Our data, and that of others, support a central role for IFN-γ in T-cell transfer models (3, 9, 37) . However, one report found that disease is dependent on T-cell expression of T-bet and Stat4, but not IFN-γ (14) . Although the basis for this discrepancy is unclear, one important variable that is inadequately controlled between studies is composition of the microbiota, which can profoundly influence the development and severity of colitis. T-cell transfers into germ-free (38) and restricted flora recipients (39) demonstrate the requirement for a complex microbiota in the induction of intestinal inflammation. In addition to commensals that can modulate the Th17 response, such as segmented filamentous bacteria (40) , "pathobionts," such as Helicobacter spp., which are common in animal facilities, can induce innate-driven colitis in immunodeficient animals (7) and can exacerbate colitis in T-cell transfer models (41) . Whether and how microbial factors might impact the influence of IFN-γ on disease pathogenesis will need to be explored going forward.
The findings herein have potential import for clinical strategies that target IBD: they suggest that interventions that prevent the transition of Th17 precursors to Th1-like cells or block effector functions of Th1 or Th1-like cells, such as IFN-γ, deserve attention. Furthermore, as the transition of Th17 precursors to Th1-like progeny involves the loss of IL-23R and RORγt expression and appears to be irreversible (15) , therapies that target RORγt + Th17 precursors or IL-23 alone might not be beneficial to all patients, at least in the setting of active disease where Th1 and Th1-like cells are abundant. Conversely, because Th17 cells express stem cell markers and appear to have greater capacity for self-renewal than Th1-like cells (42) , and might therefore serve as a reservoir of nonpathogenic cells able to transition into pathogenic, IFN-γ producing cells, therapies that deplete Th17 cells are also warranted. In this regard, antibody-based therapies that block IL-12p40 (and thus both IL-23 and IL-12) (43, 44) and IFN-γ (45) have shown promise in IBD trials, whereas blockade of IL-17A has not (46) , despite promising results in clinical trials of other Th17-driven autoimmune disorders, such as psoriasis, rheumatoid arthritis, and uveitis (47) . Thus, although the rationale for targeting the Th17 pathway remains promising in IBD, strategies that target both the Th17 and Th1 arms should be considered.
Materials and Methods
Mice. The generation of Il17f
Thy1.1 reporter mice and Ifng/Thy1.1 BAC-In (Tg) mice has been described previously (11, 28) . The following mice were purchased from the Jackson Laboratories: Tbx21 ). All mice were on a C57BL6 background, were Helicobacter spp.-negative, and were maintained in a colony in which sentinel mice tested positive for antibodies against murine norovirus. Mice were bred and maintained in accordance with the University of Alabama at Birmingham institutional animal care and use committee regulations. 
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hi cells were FACS sorted and a total of 4 × 10 5 cells were injected into age-matched Rag1 −/− recipients. Mice were monitored regularly for signs of disease and were weighed weekly. At 4 wk after transfer, mice were killed and MLNs and colons were recovered. Colons were cut longitudinally, and small lengths of tissue were obtained from the proximal, middle, and distal portions of the colon, fixed in 10% (wt/vol) formalin, and processed for histopathological analysis. Samples were scored by a pathologist in a blinded fashion as previously described (48) .
Statistical Analysis. Statistical significance was calculated using Prism software (GraphPad). The nonparametric Mann-Whitney test or Kruskal Wallis test was used to determine significance for pathology data; all other data were analyzed using t test or ANOVA. All P values ≤ 0.05 were considered significant. Further details are provided in SI Methods and Materials.
